MedTrace Logo

Marine n-3 Polyunsaturated Fatty Acids in Pre- and Postmenopausal Women

NCT00901589 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2009-05-14

No results posted yet for this study

Summary

The study is a randomised placebo controlled double-blinded clinical trial where a group of healthy pre- and postmenopausal women is randomised to the intake of fish oil capsules or placebo oil capsules for 12 weeks. Anthropometric measurements(weight, height,blood pressure) blood samples and adipose tissue biopsies will be taken in order to illustrate the effect of marine n-3 PUFAs (fish oil) on the concentration of circulating female hormones and to investigate what impact menopause might have on the ability to incorporate marine n-3 PUFAs into tissues.

Conditions

  • Postmenopause
  • Premenopause

Interventions

DIETARY_SUPPLEMENT

marine n-3 polyunsaturated fatty acids

Four capsules daily containing 2.2 g marine n-3 polyunsaturated fatty acids in total

DIETARY_SUPPLEMENT

thistle oil

four capsules a day

DIETARY_SUPPLEMENT

marine n-3 polyunsaturated fatty acids

Four capsules daily, 2.2 g marine n-3 PUFAs in total

DIETARY_SUPPLEMENT

Thistle oil

Four capsules daily

Sponsors & Collaborators

  • Aalborg University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00901589 on ClinicalTrials.gov